Literature DB >> 26555087

USP10 Expression in Normal Adrenal Gland and Various Adrenal Tumors.

Zhi Zeng1, Ziying Zhou1, Na Zhan1, Jingping Yuan1, Baixin Ye2, Lijuan Gu3, Jun Wang4, Zhihong Jian4, Xiaoxing Xiong5,6.   

Abstract

Ubiquitin-specific protease 10 (USP10), a novel deubiquitinating enzyme, is associated with androgen receptor transcriptional activity and pathological processes of tumor. However, information between USP10 and the adrenal gland is limited. In particular, the role of USP10 in adrenal tumors has not been elucidated yet. This study aims to investigate the expression of USP10 in the human normal adrenal gland and various adrenal tumors. Tissue samples were obtained from 30 adrenocortical adenomas, nine adrenocortical adenocarcinomas, and 20 pheochromocytomas following laparoscopic surgery. Twenty normal adrenal glands were obtained from kidney surgical resection conducted due to renal cell carcinomas. USP10 expression was investigated on protein levels using immunohistochemistry and on mRNA levels using bioinformatics analysis in the Gene Expression Omnibus (GEO) Datasets. In the 20 cases of normal adrenal glands analyzed, USP10 protein was constantly expressed in situ in the cortex of the adrenal glands, but in the medulla of the gland, only the sustentacular cells were detected positive. In adrenal tumors, detectable levels of USP10 protein were found in 100 % (30/30) adrenocortical adenomas, 88.89 % (8/9) adrenocortical carcinomas, and 10 % (2/20) pheochromocytomas. Bioinformatics analysis did not show a significant difference in USP10 messenger RNA (mRNA) expression between adrenal tumors and normal adrenal gland tissues. A positive USP10 immunoreaction can be useful in distinguishing adrenal cortical tumors from pheochromocytoma.

Entities:  

Keywords:  Adrenal gland; Adrenocortical adenoma; Adrenocortical carcinoma; Pheochromocytoma; USP10

Mesh:

Substances:

Year:  2015        PMID: 26555087     DOI: 10.1007/s12022-015-9406-3

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  22 in total

1.  The ubiquitin-specific protease USP10 modulates androgen receptor function.

Authors:  Hortensia Faus; Hellmuth-Alexander Meyer; Martina Huber; Inke Bahr; Bernard Haendler
Journal:  Mol Cell Endocrinol       Date:  2005-12-20       Impact factor: 4.102

2.  Deubiquitination and stabilization of T-bet by USP10.

Authors:  Lina Pan; Zuojia Chen; Linlin Wang; Chen Chen; Dan Li; Huanying Wan; Bin Li; Guochao Shi
Journal:  Biochem Biophys Res Commun       Date:  2014-05-17       Impact factor: 3.575

3.  The deubiquitinating enzyme USP10 regulates the endocytic recycling of CFTR in airway epithelial cells.

Authors:  Jennifer M Bomberger; Roxanna L Barnaby; Bruce A Stanton
Journal:  Channels (Austin)       Date:  2010 May-Jun       Impact factor: 2.581

4.  Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).

Authors:  Jessica M Grunda; L Burton Nabors; Cheryl A Palmer; David C Chhieng; Adam Steg; Tom Mikkelsen; Robert B Diasio; Kui Zhang; David Allison; William E Grizzle; Wenquan Wang; G Yancey Gillespie; Martin R Johnson
Journal:  J Neurooncol       Date:  2006-06-14       Impact factor: 4.130

5.  Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues.

Authors:  Xijin Ge; Shogo Yamamoto; Shuichi Tsutsumi; Yutaka Midorikawa; Sigeo Ihara; San Ming Wang; Hiroyuki Aburatani
Journal:  Genomics       Date:  2005-08       Impact factor: 5.736

6.  Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors.

Authors:  Sébastien Aubert; Agnès Wacrenier; Xavier Leroy; Patrick Devos; Bruno Carnaille; Charles Proye; Jean Louis Wemeau; Martine Lecomte-Houcke; Emmanuelle Leteurtre
Journal:  Am J Surg Pathol       Date:  2002-12       Impact factor: 6.394

7.  HTLV-1 Tax oncoprotein stimulates ROS production and apoptosis in T cells by interacting with USP10.

Authors:  Masahiko Takahashi; Masaya Higuchi; Grace Naswa Makokha; Hideaki Matsuki; Manami Yoshita; Yuetsu Tanaka; Masahiro Fujii
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

8.  USP10 regulates p53 localization and stability by deubiquitinating p53.

Authors:  Jian Yuan; Kuntian Luo; Lizhi Zhang; John C Cheville; Zhenkun Lou
Journal:  Cell       Date:  2010-01-21       Impact factor: 41.582

9.  The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells.

Authors:  Jennifer M Bomberger; Roxanna L Barnaby; Bruce A Stanton
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

10.  MicroRNA-191 promotes pancreatic cancer progression by targeting USP10.

Authors:  Hua Liu; Xuan-Fu Xu; Yan Zhao; Mao-Chun Tang; Ying-Qun Zhou; Jie Lu; Feng-Hou Gao
Journal:  Tumour Biol       Date:  2014-08-29
View more
  1 in total

1.  Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.

Authors:  Xing-Chun Peng; Zhi Zeng; Yu-Ning Huang; Yun-Chao Deng; Guo-Hui Fu
Journal:  Cancer Med       Date:  2018-04-17       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.